Judged:
1
1
1
Psychiatrists Label And Drug Children Solely For Profit
http://www.i-newswire.com/psychiatrists-label... ;
----------
Child psychiatry is sick with hidden conflicts of interest
Child psychiatry is sick with hidden conflicts of interest
By Dr. Leonard Sax
Sunday, December 14th 2008, 4:00 AM
When I first began writing prescriptions for children 22 years ago, it was unusual for a child to be taking powerful psychiatric drugs. Today it's common. How did we get here?
Dr. Joseph Biederman is part of the answer. He's an important guy. His title is "chief of pediatric psychopharmacology" at Massachusetts General Hospital, the main teaching hospital for Harvard Medical School. Pediatricians and family doctors look to him, and doctors like him, for guidance about what they should do with problem kids. For the past two decades, Biederman has pushed the use of medications for treating ADHD and bipolar disorder. Over the past two decades, the use of medications for treating those disorders has soared.
Sen. Charles Grassley (R-Iowa), recognizing how much influence Biederman has in promoting these medications for children, wondered whether the doctor might be taking money from drug companies. When first asked, Biederman admitted to taking perhaps "a couple hundred thousand dollars" from pharmaceutical companies. When he was asked to take another look, it turned out that Biederman and a colleague had accepted more than $1.6 million from the drug companies. And they hadn't told anybody.
Or consider the case of Dr. Fred Goodwin. After stepping down as director of the National Institute for Mental Health, Goodwin moved on to serve as the host of the NPR program "The Infinite Mind." Goodwin didn't think he needed to tell anybody that the drug companies were paying him $1.3 million, even as he reassured listeners on his program about the safety of powerful psychiatric medications for children. Last month, after his connections to the drug industry came to light, NPR canceled his program.
http://www.nydailynews.com/opinions/2008/12/1...